by Jessica Casebolt | Jun 22, 2023 | Life Sciences, Tea Leaves
The pharmaceutical industry’s largest trade group has filed a lawsuit challenging the constitutionality of President Biden’s drug-price negotiation law, the latest legal test of a program that could cost drugmakers billions of dollars over the next decade. The...
by Jessica Casebolt | Jun 22, 2023 | Access & Coverage, Tea Leaves
In a KFF survey of 569 board-certified OB-GYNs across the U.S., 68 percent say the Supreme Court’s reversal of Roe v. Wade has worsened pregnancy-related medical emergencies, while 64 percent report that the ruling has worsened pregnancy-related mortality. The...
by Jessica Casebolt | Jun 21, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The American Society of Addiction Medicine (ASAM) is accepting applications for expert writing group members to develop and draft the Adolescent volume of the 4th Edition of The ASAM Criteria. The Adolescent volume of the 4th Edition of The ASAM Criteria will update...
by Jessica Casebolt | Jun 21, 2023 | Mental Health, Tea Leaves
According to a new recommendation from the US Preventive Services Task Force released Tuesday, adults ages 19 to 64 in the United States should be screened for anxiety disorders. Thefinal recommendation, published in the medical journal JAMA, marks the first time the...
by Jessica Casebolt | Jun 21, 2023 | M&A, Tea Leaves
Eli Lilly announced Tuesday that it has entered into a deal to acquire Dice Therapeutics for $2.4 billion, a move that will bulk up its treatment portfolio for immune-related diseases. Dice is a biopharmaceutical company that uses a proprietary technology platform to...
by Jessica Casebolt | Jun 21, 2023 | Access & Coverage, Tea Leaves
A federal judge struck down Arkansas’ first-in-the-nation ban on gender-affirming care for children as unconstitutional Tuesday, the first ruling to overturn such a prohibition as a growing number of Republican-led states adopt similar restrictions. S. District Judge...
Recent Comments